SCHEMBL21031221

SCHEMBL21031221

c1ccc(-c2ccc(-c3cc(-c4cccc(-c5c6ccccc6nc6sc7ccccc7c56)c4)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.41
▸ KMT2A Q03164 6/20 0.41
▸ HPGD P15428 6/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ MAPT P10636 5/20 0.41
▸ LMNA P02545 4/20 0.41
▸ KDM4E B2RXH2 4/20 0.41
▸ GLA P06280 1/20 0.41
▸ NTSR1 P30989 1/20 0.40
▸ DHODH Q02127 1/20 0.38
▸ ACHE P22303 1/20 0.36
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ ADORA2A P29274 2/20 0.35
▸ ADORA1 P30542 2/20 0.35
▸ SCD O00767 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ ABCG2 Q9UNQ0 2/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ ACACA Q13085 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21030961 0.97 MEN1 (0.40) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21032053 0.97 MEN1 (0.40) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21031222 0.96 MEN1 (0.39) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21031446 0.96 MEN1 (0.39) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21031224 0.96 MEN1 (0.36) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL25847652 0.95 MEN1 (0.41) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21030952 0.94 MEN1 (0.42) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21030953 0.94 MEN1 (0.42) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21031450 0.93 MEN1 (0.40) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL25847633 0.93 MEN1 (0.43) MEN1KMT2AHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885HPGD 2093/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 MEN1 3802/4885KMT2A 1221/4885HPGD 2093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback